CPT1A and metabolic dysfunction-associated steatotic liver disease: By constructing NAFLD mice and cell models, we observed the pathological changes of liver injury, and detected the key proteins in the AMPK/ACC/CPT1 and the AMPK/SREBP1/Scd1 pathways.